Determination of comparative minimum inhibitory concentration (MIC) of bacteriocins produced by enterococci for

Maryam Hassan1, Yousef Javadzadeh, Farzaneh Lotfipour

  • 1Faculty of Pharmacy and Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Abstract

Insights

Multi-antibiotic resistant enterococci pose a global health threat. Prokaryotic antimicrobial peptides show promise as alternatives to conventional antibiotics, demonstrating notable activity against resistant strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Multi-antibiotic resistance in enterococci is a significant worldwide clinical challenge.
  • Limited effective therapeutic options exacerbate the problem of enterococcal infections.
  • Prokaryotic antimicrobial peptides (bacteriocins) offer a potential alternative to conventional antibiotics.

Purpose of the Study:

  • To evaluate the antibiotic susceptibility patterns of clinical enterococcal isolates.
  • To screen these isolates for antibacterial activity against indicator strains.
  • To assess the efficacy of bacteriocinogenic isolates against multi-antibiotic resistant Enterococcus spp.

Main Methods:

  • Evaluated antibiotic susceptibility of 20 clinical enterococcal isolates.
  • Screened isolates for antibacterial activity against three indicator strains.
  • Determined Minimum Inhibitory Concentration (MIC) of bacteriocinogenic isolates against resistant Enterococcus spp.

Main Results:

  • A high prevalence of multi-antibiotic resistance was observed in enterococcal isolates.
  • Common resistance patterns included combinations of gentamicin, streptomycin, chloramphenicol, and vancomycin.
  • Selected bacteriocinogenic strains exhibited significant inhibitory activity against pathogenic enterococci.

Conclusions:

  • Antimicrobial peptides derived from prokaryotes show potential for combating antibiotic resistance.
  • This study highlights the applicability of bacteriocins as a strategy against multi-drug resistant enterococci.